Novo Nordisk A/S 13D/13G Filings for

Novo Nordisk A/S 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2025-10-21
08:00 am
Sale		2025-07-1413GInnate Pharma S.A.
IPHA		Novo Nordisk A/S8,895,649
9.650%		-921,897decrease
(-9.39%)		Filing